LifeSci Capital Initiates Aura Biosciences(AURA.US) With Buy Rating, Announces Target Price $23

Moomoo NewsMar 3 12:32 ET · Ratings

Promising Developments in Aura Biosciences Inc's Clinical Trials Lead to Buy Rating

TipRanksMar 3 12:25 ET · Ratings

H.C. Wainwright Maintains Aura Biosciences(AURA.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsMar 3 11:31 ET · Ratings

Aura Biosciences Announces Additional Phase 1 Data on Bel-sar

TipRanksMar 3 07:22 ET

Express News | Aura Biosciences Announces Additional Data From Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to Be Presented as a Late-Breaking Abstract at the 40TH Annual European Association of Urology Congress

ReutersMar 3 07:00 ET

Aura Biosciences Announces Additional Data From Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to Be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urology Congress

GlobeNewswireMar 3 07:00 ET